Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label First-line axitinib ‘ advanced. Show all posts
Showing posts with label First-line axitinib ‘ advanced. Show all posts
Tuesday, August 25, 2015

First-line axitinib ‘feasible’ in advanced, metastatic RCC

›
We know that, Axitinib (AG013736; trade name Inlyta) is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has bee...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.